| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/04/1993 | EP0543949A4 Enzymic alteration of hair growth |
| 08/04/1993 | EP0536119A4 Immunoregulatory agents |
| 08/04/1993 | EP0505374A4 Vitamin-mineral treatment methods and compositions |
| 08/04/1993 | EP0445158B1 Preparations of oxypurinol and/or its alkali or alkaline earth salts |
| 08/04/1993 | EP0355135B1 Adenosine deaminase-stable anti-retroviral nucleosides |
| 08/04/1993 | EP0355095B1 Pharmacological agent-lipid solution preparation |
| 08/04/1993 | EP0351435B1 Fused pyridazine compounds and their medicinal uses |
| 08/04/1993 | EP0305493B1 Cosmetic base composition with therapeutic properties |
| 08/04/1993 | EP0182851B1 Primycin components and process for the separation of the antibiotic complex |
| 08/04/1993 | CN1074937A 4,5-dihydro geldanamycin, preparation of its hydroquinone, and applications |
| 08/04/1993 | CN1074908A 水溶性喜树碱衍生物 Water-soluble derivative of camptothecin |
| 08/04/1993 | CN1074907A Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidizole derivatives |
| 08/04/1993 | CN1074906A New 4-cinnolinyl- and 4-naphthyridinyl-dihydropyridines, processes for their preparation and their use in medicaments |
| 08/04/1993 | CN1074905A Pyrrolylbenzodiazepinones |
| 08/04/1993 | CN1074904A Benzofuranyl and thiophenylmethylthio-alkanecarboxylic acid derivatives |
| 08/04/1993 | CN1074903A Substituted hexahyhdroazepinones and tetrahydrobenzazepinones |
| 08/04/1993 | CN1074827A Cholecalciferol-cholesterol emulsion and its preparing process |
| 08/04/1993 | CN1074826A Pharmaceutical compositions |
| 08/04/1993 | CN1021735C Process for preparation of cephalosporin compounds |
| 08/04/1993 | CN1021734C Process for preparing pyrimido |5, 4-b¨ |1, 4¨ oxazine derivs. |
| 08/04/1993 | CN1021733C Process for preparation of indolylpiperidine compounds |
| 08/04/1993 | CA2107461A1 Remedy for dermatopathy and metallothionein inducer |
| 08/03/1993 | US5233031 Phosphoramidate analogs of 2'-deoxyuridine |
| 08/03/1993 | US5232950 Method for using ketamine for prevention or reduction of the effects of stroke in a subject having increased risk for stroke |
| 08/03/1993 | US5232948 Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
| 08/03/1993 | US5232947 Administering to ameliorate damage from anoxia |
| 08/03/1993 | US5232946 Promoting weight gain and reduction of blood sugar and fat deposits in animals, feed efficiency |
| 08/03/1993 | US5232945 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives |
| 08/03/1993 | US5232941 Caffeic acid derivatives and pharmaceutical compositions containing the same |
| 08/03/1993 | US5232940 Derivatives of N-phenylpyrazoles |
| 08/03/1993 | US5232939 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents |
| 08/03/1993 | US5232934 Method for the treatment of psychomotor stimulant addiction |
| 08/03/1993 | US5232933 Method for treatment of neurodegenerative diseases |
| 08/03/1993 | US5232932 Method for treatment of neurodegenerative diseases |
| 08/03/1993 | US5232931 Sedatives, tranquilizers, antidepressants, neuroleptic agents |
| 08/03/1993 | US5232930 2-heteroaryl-substituted benzodioxoic having 5-lipoxygenase inhibitory activity |
| 08/03/1993 | US5232929 Treatment and prevention of inflammatory and central nervous system disorders |
| 08/03/1993 | US5232922 Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediates |
| 08/03/1993 | US5232920 N-(mercaptoalkyl)amides |
| 08/03/1993 | US5232918 Cephalosporin derivatives |
| 08/03/1993 | US5232917 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 08/03/1993 | US5232915 9α-hydroxy-19,11β-bridged steroids, their production and pharmaceutical preparations containing these steroids |
| 08/03/1993 | US5232914 Solid, storage-stable, germicidal, pre-iodine composition |
| 08/03/1993 | US5232837 Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination |
| 08/03/1993 | US5232769 Microcapsule, treating liquids containing the same, and textile structure having microcapsules adhering thereto |
| 08/03/1993 | US5232706 Oral pharmaceutical preparation containing omeprazol |
| 08/03/1993 | US5232703 Ointment, gel, film containing mixture of estrogen and uncrosslinked water insoluble vinylpyrrolidone copolymer |
| 08/03/1993 | US5232700 Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient |
| 08/03/1993 | US5232699 Containing psyllium and sennoside in palatable food grade fat and sweetener; baked wafer; for humans and animals |
| 08/03/1993 | US5232693 Topically administering endcapped polysiloxane |
| 08/03/1993 | US5232692 Administering an aqueous solution of povidone-iodine having a specified concentration to the eyes of a human infant to prevent infection by neisseria or chlamydia |
| 08/03/1993 | US5232686 Treating chronic damage to mucosa and walls of stomach, caused by long term consumptionof nonsteroidal antiinflammatory agent, administering morpholinium salt |
| 08/03/1993 | CA1320964C Thiophene derivative and process for preparing the same |
| 08/03/1993 | CA1320959C 4h-1-benzopyran-4-one derivative or its salt, processes for producing the same and pharmaceutical composition comprising the same as active ingredient |
| 08/03/1993 | CA1320958C 2-carbonyl substituted n,n'-di-(trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them |
| 08/03/1993 | CA1320957C Pyridazinone derivatives |
| 08/03/1993 | CA1320954C .alpha.-adrenergic receptor antagonists |
| 08/03/1993 | CA1320953C .alpha.-adrenergic receptor antagonists |
| 08/03/1993 | CA1320952C Antitumor alkaloids |
| 08/03/1993 | CA1320951C Disaccharide derivatives |
| 08/03/1993 | CA1320950C Macrolide compounds |
| 08/03/1993 | CA1320909C Topical composition for the treatment of mucocutaneous lesions |
| 08/03/1993 | CA1320908C Diaryl compounds and their use |
| 08/03/1993 | CA1320904C Method for the treatment of atherosclerosis, thrombosis and peripheral vessel disease |
| 08/03/1993 | CA1320885C Controlled porosity osmotic pump |
| 08/01/1993 | CA2088464A1 A new pyridine bicyclic derivatives, process for preparing the same, new intermediates obtained, apllication of the same as drugs, and pharmac eutical compositions containing thesame |
| 08/01/1993 | CA2088396A1 Pyridine derivatives |
| 07/31/1993 | CA2088390A1 Tetrahydropyrimidine derivatives and pharmaceutical compositions containing them |
| 07/31/1993 | CA2088347A1 Substituted triazoles as angiotensin ii inhibitors |
| 07/31/1993 | CA2088209A1 4-cinnolinyl- and 4-naphthyridinyl-dihydropyridines, processes for their preparation and their use in medicaments |
| 07/31/1993 | CA2087504A1 Administration of low dose hemoglobin to increase perfusion |
| 07/29/1993 | DE4202665A1 Prostacyclin- und carbacyclinderivate als mittel zur behandlung von multipler sklerose Prostacyclin and carbacyclin derivatives as an agent for treatment of multiple sclerosis |
| 07/29/1993 | DE4202184A1 Substd. salicylaldehyde derivs. for treating type II diabetes - inhibit glucose-6-phosphatase and gluco-neo genesis in mammals |
| 07/29/1993 | DE4201554A1 New benzimidazol-1-yl-methyl-bi:phenyl derivs. |
| 07/29/1993 | CA2088220A1 Heterocyclic derivatives |
| 07/29/1993 | CA2088173A1 Process for the preparation of ceftriaxon disodium salt hemiheptahydrate |
| 07/28/1993 | EP0553016A1 New naphthalene amides and sulfonamides, process for their preparation and pharmaceutical compositions containing them |
| 07/28/1993 | EP0552974A1 A 1-aryl-2-(1H-1,2-4-triazol-1-yl) ethanol derivative and antifungal compositions containing that derivative |
| 07/28/1993 | EP0552881A1 Anticancer benzaldehyde compounds |
| 07/28/1993 | EP0552880A1 Anticancer benzaldehyde compounds |
| 07/28/1993 | EP0552879A1 Improved iontophoretic administration of drugs |
| 07/28/1993 | EP0552818A2 Milbemycin ether derivatives, their preparation and their therapeutic and agrochemical uses |
| 07/28/1993 | EP0552817A2 Milbemycin ether derivatives, their preparation and their therapeutic and agrochemical uses |
| 07/28/1993 | EP0552767A2 3'-derivatised oligonucleotide analogues with non-nucleotidic groups, their preparation and use |
| 07/28/1993 | EP0552766A2 Oligonucleotide analogues, their preparation and use |
| 07/28/1993 | EP0552765A1 Benzimidazoles, pharmaceutical compositions containing them and process for their preparation |
| 07/28/1993 | EP0552665A1 Pyrrolylbenzodiazepinones and medicines containing them |
| 07/28/1993 | EP0552657A1 Use of pure Boswellic acid |
| 07/28/1993 | EP0552631A1 Alpha-aryl-alpha-hydroxy-beta-imidazolinylpropionamides |
| 07/28/1993 | EP0552624A1 Pharmaceutical compositions containing 9-cis retinoic acid, salts and esters thereof |
| 07/28/1993 | EP0552553A1 Sulfonimidamides as antineoplastic agents |
| 07/28/1993 | EP0552552A2 5-Deazafolic acid derivatives and their use as antineoplastics agents |
| 07/28/1993 | EP0552516A1 Aqueous synthetic organ-extracts |
| 07/28/1993 | EP0552462A1 Thiadiazinecarboxamides, process for their preparation and pharmaceuticals |
| 07/28/1993 | EP0552439A1 Pharmaceutical preparations for topical use in the treatment of psoriasis and atopical dermatitis |
| 07/28/1993 | EP0552379A1 Dihydropyridine derivatives, and process for their preparation. |
| 07/28/1993 | EP0552373A1 Apoptosis regulator |
| 07/28/1993 | EP0552329A1 Methylen-oxindole derivatives and process for their preparation |
| 07/28/1993 | EP0552309A1 New process for biophosphorylating organic compounds |
| 07/28/1993 | EP0552289A1 Prevention or treatment of sunburn using the s(+) isomer of ketoprofen |